メキシレチン
- 同
- Mexitil
WordNet
- antiarrhythmic drug (trade name Mexitil) used to treat ventricular arrhythmias (同)Mexitil
Wikipedia preview
出典(authority):フリー百科事典『ウィキペディア(Wikipedia)』「2014/10/19 13:37:11」(JST)
[Wiki en表示]
Mexiletine
|
Systematic (IUPAC) name |
(RS)-1-(2,6-dimethylphenoxy)propan-2-amine
OR
2-(2-aminopropoxy)-1,3-dimethylbenzene |
Clinical data |
AHFS/Drugs.com |
monograph |
MedlinePlus |
a607064 |
Pregnancy cat. |
|
Legal status |
|
Routes |
Oral, IV |
Pharmacokinetic data |
Bioavailability |
90% |
Protein binding |
50-60% |
Metabolism |
Hepatic (CYP2D6 and 1A2- mediated) |
Half-life |
10-12 hours |
Excretion |
Renal (10%) |
Identifiers |
CAS number |
31828-71-4 Y |
ATC code |
C01BB02 |
PubChem |
CID 4178 |
IUPHAR ligand |
2629 |
DrugBank |
DB00379 |
ChemSpider |
4034 Y |
UNII |
1U511HHV4Z Y |
KEGG |
D08215 Y |
ChEBI |
CHEBI:6916 Y |
ChEMBL |
CHEMBL558 Y |
Chemical data |
Formula |
C11H17NO |
Mol. mass |
179.259 g/mol |
|
InChI
-
InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3 Y
Key:VLPIATFUUWWMKC-UHFFFAOYSA-N Y
|
Y (what is this?) (verify) |
Mexiletine (INN, sold under the trade name Mexitil) belongs to the Class IB anti-arrhythmic group of medicines. It is used to treat arrhythmias within the heart, or seriously irregular heartbeats. It slows conduction in the heart and makes the heart tissue less sensitive. Dizziness, heartburn, nausea, nervousness, trembling, unsteadiness are common side effects. It is available in injection and capsule form.
Class IB antiarrhythmics decrease action potential frequency by lengthening the repolarization phase. This is achieved by blocking sodium channels.[1]
This drug is now no longer freely available as a licensed product in either the US or the UK. It can be imported to the UK as an unlicensed, 'named-patient' drug. Its use in arrhythmias is restricted to use in life-threatening conditions only.
Mexiletine may also be of use in patients experiencing refractory pain[2] and is also effective for treating muscle stiffness resulting from myotonic dystrophy (Steinert's disease) or nondystrophic myotonias such as myotonia congenita (Thomsen disease).
Contents
- 1 Synthesis
- 2 References
- 3 Further reading
- 4 External links
Synthesis
Mexiletine synthesis:
[3][4][5][6]
References
- ^ Mexiletine, RxList.com
- ^ Sweetman S (ed.) (2002). Martindale: The complete drug reference (33rd ed.). London: Pharmaceutical Press. ISBN 0-85369-499-0.
- ^ H. Koppe, W. Kummer, U.S. Pat. 3.954.872 (1976).
- ^ H. Koppe, W. Kummer, U.S. Pat. 3.659.019 (1972).
- ^ C.H. Boehringer Sohns, Fr. Pat. 1.551.055 (1968).
- ^ H. Koppe, W. Kummer, U.S, Pat. 4.031.244 (1977).
Further reading
- Peck T; Hill S, Williams M (eds.) (2004). Pharmacology for Anaesthesia and Intensive Care (2nd ed.). Cambridge University Press. ISBN 0-521-68794-2.
External links
- MedlinePlus Drug Information: Mexiletine
Antiarrhythmic agents (C01B)
|
|
Channel blockers |
class I
(Na+ channel blockers)
|
class Ia (Phase 0→ and Phase 3→)
|
- Ajmaline
- Disopyramide
- Lorajmine
- Prajmaline
- Procainamide#
- Quinidine#
- Sparteine
|
|
class Ib (Phase 3←)
|
- IV (Lidocaine#)
- enteral (Aprindine
- Mexiletine
- Tocainide)
|
|
class Ic (Phase 0→)
|
- Encainide‡
- Ethacizine
- Flecainide
- Indecainide‡
- Lorcainide
- Moracizine‡
- Propafenone
|
|
|
class III
(Phase 3→, K+ channel blockers)
|
- Amiodarone
- Bretylium
- Bunaftine
- Dofetilide
- Dronedarone
- E-4031†
- Ibutilide
- Nifekalant
- Sotalol
- Tedisamil
- Vernakalant
|
|
class IV
(Phase 4→, Ca2+ channel blockers)
|
|
|
|
Receptor agonists
and antagonists |
class II
(Phase 4→, β blockers)
|
- Nadolol
- Pindolol
- Propranolol
- cardioselective (Acebutolol
- Atenolol
- Esmolol
- Metoprolol)
|
|
A1 agonist
|
- Adenosine
- Benzodiazepines
- Barbiturates
|
|
M2
|
- muscarinic antagonist: Atropine
- Disopyramide
- Quinidine
muscarinic agonist: Digoxin
|
|
α receptors
|
- Amiodarone
- Bretylium
- Quinidine
- Verapamil
|
|
|
Ion transporters |
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
|
|
noco/cong/tumr, sysi/epon, injr
|
proc, drug (C1A/1B/1C/1D), blte
|
|
|
|
Analgesics (N02A, N02B)
|
|
Opioids |
Opiates/opium
|
- Codeine#
- Morphine#
- Opium
- Laudanum
- Paregoric
|
|
Semisynthetic
|
- Acetyldihydrocodeine
- Benzylmorphine
- Buprenorphine
- Desomorphine
- Diacetylmorphine (heroin)
- Dihydrocodeine
- Dihydromorphine
- Ethylmorphine
- Hydrocodone
- Hydromorphinol
- Hydromorphone
- Nicocodeine
- Nicodicodeine
- Nicomorphine
- Oxycodone
- Oxymorphone
|
|
Synthetic
|
- Alphaprodine
- Anileridine
- Butorphanol
- Dextromoramide
- Dextropropoxyphene
- Dezocine
- Fentanyl
- Ketobemidone
- Levorphanol
- Meptazinol
- Methadone
- Nalbuphine
- Pentazocine
- Pethidine
- Phenazocine
- Piminodine
- Piritramide
- Propiram
- Tapentadol
- Tilidine
- Tramadol
|
|
|
Pyrazolones |
- Aminophenazone
- Ampyrone
- Metamizole
- Phenazone
- Propyphenazone
|
|
Anilides |
- Paracetamol (acetaminophen)#
- Phenacetin
- Propacetamol
|
|
NSAIDs |
Propionic acids
|
- Fenoprofen
- Flurbiprofen
- Ibuprofen#
- Ketoprofen
- Naproxen
- Oxaprozin
|
|
Oxicams
|
|
|
Acetic acids
|
- Diclofenac
- Indometacin
- Ketorolac
- Nabumetone
- Sulindac
- Tolmetin
|
|
COX-2 inhibitors
|
- Celecoxib
- Lumiracoxib
- Parecoxib
- Rofecoxib
- Valdecoxib
|
|
Fenamates
|
- Meclofenamic acid
- Mefenamic acid
|
|
Salicylates
|
- Aspirin (acetylsalicylic acid)# (+paracetamol/caffeine)
- Benorylate
- Diflunisal
- Ethenzamide
- Magnesium salicylate
- Salicin
- Salicylamide
- Salsalate
- Wintergreen (methyl salicylate)
|
|
Others
|
|
|
|
Cannabinoids |
- Cannabidiol
- Cannabis
- Nabilone
- Nabiximols
- Tetrahydrocannabinol (dronabinol)
|
|
Channel modulators |
Calcium blockers
|
- Gabapentin
- Gabapentin enacarbil
- Pregabalin
- Ziconotide
|
|
Sodium blockers
|
- Carbamazepine
- Lacosamide
- Local anesthetics (e.g., lidocaine)
- Mexiletine
- Nefopam
- Orphenadrine
- Tricyclic antidepressants (e.g., amitriptyline#)
|
|
Potassium openers
|
|
|
|
Monoaminergics |
- Bupropion
- Nefopam
- Orphenadrine
- SNRIs (e.g., duloxetine)
- Tapentadol
- Tramadol
- TCAs (e.g., amitriptyline#)
|
|
Muscle relaxants |
- Carisoprodol
- Chlorzoxazone
- Cyclobenzaprine
- Mephenoxalone
- Methocarbamol
- Orphenadrine
|
|
Others |
- Bupropion
- Camphor
- Capsaicin
- Clonidine
- Ketamine
- Menthol
- Methoxyflurane
- Proglumide
|
|
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
|
|
|
anat (n/s/m/p/4/e/b/d/c/a/f/l/g)/phys/devp
|
noco (m/d/e/h/v/s)/cong/tumr, sysi/epon, injr
|
proc, drug (N1A/2AB/C/3/4/7A/B/C/D)
|
|
|
|
Neuropathic pain and fibromyalgia pharmacotherapies
|
|
Monoaminergics |
- SNRIs (e.g., duloxetine, milnacipran)
- TCAs (e.g., amitriptyline, nortriptyline, desipramine)
- Tapentadol
- Tramadol
|
|
Ion channel blockers |
- Anticonvulsants (e.g., gabapentin, pregabalin, carbamazepine, oxcarbazepine, lamotrigine)
- Local anesthetics (e.g., lidocaine)
- Mexiletine
- TCAs (e.g., amitriptyline, nortriptyline, desipramine)
- Ziconotide
|
|
Others |
- Alpha lipoic acid
- Benfotiamine
- Botulinum toxin A
- Bupropion
- Cannabinoids (e.g., cannabis, dronabinol, nabilone)
- NMDAR antagonists (e.g., ketamine, dextromethorphan, methadone)
- Opioids (e.g., hydrocodone, morphine, oxycodone, methadone, tramadol, tapentadol)
- Sodium oxybate (GHB)
|
|
Channelergics
|
|
Blockers |
|
|
Openers |
Potassium
(K+)
|
- Aprikalim
- Bimakalim
- Cromakalim
- Diazoxide
- Emakalim
- Flupirtine
- Levcromakalim
- Mazokalim
- Minoxidil
- Naminidil
- Nicorandil
- Pinacidil
- Retigabine
- Rilmakalim
- Rottlerin
- Sarakalim
|
|
|
UpToDate Contents
全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.
English Journal
- A Case of Long QT Syndrome Type 3 Aggravated by Beta-Blockers and Alleviated by Mexiletine: The Role of Epinephrine Provocation Test.
- Park J, Kim SK, Pak HN.SourceDepartment of Cardiology, Yonsei University Health System, 50 Yonsei-ro, Seodaemun-gu, Seoul 120-752, Korea. hnpak@yuhs.ac.
- Yonsei medical journal.Yonsei Med J.2013 Mar 1;54(2):529-33. doi: 10.3349/ymj.2013.54.2.529.
- Long QT syndrome (LQTs) is an uncommon genetic disease causing sudden cardiac death with Torsade de Pointes (TdP). The first line drug treatment has been known to be β-blocker. We encountered a 15-year-old female student with LQTs who had prolonged QTc and multiple episodes of syncope or agonal res
- PMID 23364992
- Molecular dissection of lubeluzole use-dependent block of voltage-gated sodium channels discloses new therapeutic potentials.
- Desaphy JF, Carbonara R, Costanza T, Lentini G, Cavalluzzi MM, Bruno C, Franchini C, Camerino DC.SourceSection of Pharmacology, Department of Pharmacy, University of Bari-Aldo Moro, via Orabona 4 - campus, I-70125 Bari, Italy. jfdesaphy@farmbiol.uniba.it.
- Molecular pharmacology.Mol Pharmacol.2013 Feb;83(2):406-15. doi: 10.1124/mol.112.080804. Epub 2012 Nov 21.
- Lubeluzole, which acts on various targets in vitro, including voltage-gated sodium channels, was initially proposed as a neuroprotectant. The lubeluzole structure contains a benzothiazole moiety [N-methyl-1,3-benzothiazole-2-amine (R-like)] related to riluzole and a phenoxy-propranol-amine moiety [(
- PMID 23175529
- In vivo evaluation of antimyotonic efficacy of β-adrenergic drugs in a rat model of myotonia.
- Desaphy JF, Costanza T, Carbonara R, Conte Camerino D.SourceSection of Pharmacology, Department of Pharmacy, University of Bari-Aldo Moro, Via Orabona 4 - Campus, 70125 Bari, Italy. jfdesaphy@farmbiol.uniba.it
- Neuropharmacology.Neuropharmacology.2013 Feb;65:21-7. doi: 10.1016/j.neuropharm.2012.09.006. Epub 2012 Sep 18.
- The sodium channel blocker mexiletine is considered the first-line drug in myotonic syndromes, a group of muscle disorders characterized by membrane over-excitability. We previously showed that the β-adrenoceptor modulators, clenbuterol and propranolol, block voltage-gated sodium channels in a mann
- PMID 23000075
Japanese Journal
- Column-Switching HPLC Determination of Mexiletine Using Tris(bipyridine)ruthenium(III) Electrogenerated Chemiluminescence and Precolumn Derivatization with Divinylsulfone
- KOBAYASHI Naoko,MIYAMOTO Aoi,UCHIKURA Kazuo
- Analytical sciences : the international journal of the Japan Society for Analytical Chemistry 26(12), 1289-1294, 2010-12-10
- NAID 10027575018
- 福田 悟,南部 隆,高橋 秀則,黒木 佳奈子,西山 比呂史,三潴 忠道
- 日本東洋醫學雜誌 = Japanese journal of oriental medicine 61(7), 912-916, 2010-11-20
- 釣藤散により帯状疱疹による眼症状が劇的に改善した2症例を経験した。症例1は78歳女性で20年前の帯状疱疹による眼内異物感とひりひりする痛みを訴え,既往に高血圧があった。週1回の星状神経節ブロック,桂枝加朮附湯エキス,アミトリプチリンおよび後にメキシレチンで治療した。最初,神経ブロックの効果は劇的であったが,その効果は1カ月間で徐々に減少した。星状神経節ブロックと釣藤散の共通作用である頭蓋内血流の増 …
- NAID 10026966738
Related Links
- Mexiletine official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more. ... Electrophysiology in Man Mexiletine is a Class 1B antiarrhythmic compound with ...
- Before taking mexiletine, tell your doctor and pharmacist if you are allergic to mexiletine, lidocaine, any other medications, or any of the ingredients in mexiletine. Ask your pharmacist for a list of the ingredients. tell your ...
Related Pictures
★リンクテーブル★
[★]
- 英
- drug-induced hypersensitivity syndrome DIHS
- 同
- drug rash with eosinophilia and systemic symptoms DRESS,drug-induced delayed multiorgan hypersensitivity syndrome DIDMOS
- 関
- 薬疹
概念
- 高熱と臓器障害を伴う薬疹で、医薬品中止後も遷延化する。多くの場合、発症後2-3週間後にHHV-6の再活性化を生じる。(参考1)
病因
原因薬物
- 原因薬物としては芳香族抗てんかん薬とスルホンアミド系抗菌薬が最も多い (参考2)
- 参考3
病態
- 特定の薬剤を服用した2-6週間後に突然の発熱と紅斑を来たし、ついには紅皮症を呈する。
- リンパ節腫脹、血液学的異常、肝機能障害を伴う。
- 肺炎、腎不全、心筋炎、甲状腺炎、神経学的症状を呈することがある。(参考2)
症状
身体所見
検査
- 血算:白血球増多、異型リンパ球有り、好酸球増多
- 血清学的検査:IgM-抗HHV-6抗体陽性
検査異常の出現頻度
- 参考2
- 肝炎:51%
- 間質性腎炎:11%
- 血液学的異常(好酸球増多、異型単核球):30%
診断基準
- 参考1
- 1. 限られた薬剤投与後に遅発性に生じ、急速に拡大する紅斑。多くの場合、紅皮症に移行する
- 2. 原因薬剤中止後も2週間以上遷延する
- 3. 38 ℃以上の発熱
- 4. 肝機能障害
- 5. 血液学的異常:a、b、c のうち1 つ以上
- a. 白血球増多(11,000/mm3 以上)
- b. 異型リンパ球の出現(5%以上)
- c. 好酸球増多(1,500/mm3 以上)
- 典型DIHS:1 - 7 すべて
- 非典型DIHS:1 - 5 すべて。ただし4 に関しては、その他の重篤な臓器障害をもって代えることができる。
治療
- 薬剤の中止、全身ステロイド療法(要するに静注ということか)。(参考1)
予後
- 完全に治癒する。重症例では生命予後不良。(参考1)
参考
- 1. 重篤副作用疾患別対応マニュアル 薬剤性過敏症症候群
- http://www.mhlw.go.jp/topics/2006/11/dl/tp1122-1a09.pdf
- 2. [charged] Drug eruptions - uptodate [1]
- CLASSIC DRUG REACTION PATTERNSの1項目として記載。
- www.eiken.co.jp/modern_media/backnumber/pdf/MM1012_01.pdf
国試
[★]
- 英
- mexiletine
- 化
- 塩酸メキシレチン mexiletine hydrochloride
- 商
- チルミメール、トイ、ポエルテン、メキシチール、メキシバール、メキシレート、メキトライド、メルデスト、メレート、モバレーン
[★]
- 関
- mexiletine